HLCO Zgłoszenia SEC - The Healing Company Inc.- Raport roczny, oświadczenie o pełnomocnictwie, Prospekt

Podstawowe statystyki

CIK

1441082

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to The Healing Company Inc.

SEC Filings (Chronological Order)

Na tej stronie znajduje się pełna, chronologiczna lista zgłoszeń SEC, z wyłączeniem zgłoszeń własności, które udostępniamy gdzie indziej.

February 23, 2024	8-K	Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2024 (February 15, 2024) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of inco
February 14, 2024	NT 10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-56551 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-56551 ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Rep
November 20, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-56551 THE HEALING COMPANY
November 17, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2023 (November 13, 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2023 (November 13, 2023) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 000-56551 26-2862618 (State or other jurisdiction of incor
November 14, 2023	NT 10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-56551 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-56551 ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Re
November 2, 2023	SC 13G	HLCO / Healing Company Inc (The) / Argyropoulos Demetri - SC 13G Passive Investment SC 13G 1 hlcosc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 The Healing Company Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 88336Y105 (CUSIP Number) October 25, 2023 (Date of Event which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to
November 2, 2023	SC 13G	HLCO / Healing Company Inc (The) / Oelmann Anabel - SC 13G Passive Investment SC 13G 1 hlcosc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 The Healing Company Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 88336Y105 (CUSIP Number) May 10, 2023 (Date of Event which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to whi
October 23, 2023	EX-21.1	List of subsidiaries EXHIBIT 21.1 Exhibit 21.1 List of Subsidiaries Subsidiaries of The Healing Company Inc.: · NOEO, GmbH, a German limited liability company (Gesellschaft mit beschränkter Haftung), 100% controlled · NOEO, Inc., a Nevada Corporation, 100% controlled · HLCO Borrower LLC, a Delaware limited liability company, 100% controlled Subsidiaries of HLCO Borrower LLC: · Your Super HLCO LLC, a Delaware limited l
October 23, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-152805 THE HEALING COMPANY INC. (Exact
October 4, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2023 (October 2, 2023) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2023 (October 2, 2023) THE HEALING COMPANY, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorpo
September 28, 2023	NT 10-K	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-56551 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-56551 ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report
September 7, 2023	EX-99.2	THE HEALING COMPANY FORGES STRATEGIC PARTNERSHIP WITH ALTHEA DRF LIFESCIENCES EXHIBIT 99.2 THE HEALING COMPANY FORGES STRATEGIC PARTNERSHIP WITH ALTHEA DRF LIFESCIENCES The Healing Company, Inc. August 24, 2023 The Healing Company, Inc. The Renowned Biosciences Research Company Expected to Propel The Healing Company’s Growth & Product Innovation New York, NY, Aug. 24, 2023 (GLOBE NEWSWIRE) - The Healing Company Inc. (OTCQB: HLCO) (“The Healing Company” or the “Company”) tod
September 7, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2023 (September 7, 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2023 (September 7, 2023) THE HEALING COMPANY, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of inc
September 7, 2023	EX-99.1	The Healing Company Appoints Biotech Visionaries Dr. Linda Friedland and Dr. Peter Kash as Advisors EXHIBIT 99.1 The Healing Company Appoints Biotech Visionaries Dr. Linda Friedland and Dr. Peter Kash as Advisors New York, NY, September 7, 2023 (Globe Newswire) - The Healing Company Inc. (OTCQB: HLCO) (“The Healing Company” or the “Company”) today announced the appointment of renowned biotech entrepreneurs and investors, Dr. Linda Friedland and Dr. Peter Kash, to the Company’s advisory board. Dr
August 28, 2023	EX-99.1	Independent Auditors’ Report EXHIBIT 99.1 CHOPRA GLOBAL LLC STANDALONE LICENSING, PRODUCT AND DIGITAL BUSINESS TABLE OF CONTENTS Pages Independent Auditors’ Reports 2 Statements of revenues and direct expenses the years ended December 31, 2022 and 2021 3 Statements of net liabilities assumed as of December 31, 2022 and 2021 4 Notes to the statements of revenues and direct expenses and statements of net liabilities assumed 5 1
August 28, 2023	EX-99.2	THE HEALING COMPANY INC. UNAUDITED PROFORMA CONDENSED CONSOLIDTED BALANCE SHEET (in thousands) EXHIBIT 99.2 The following unaudited pro forma condensed consolidated balance sheet as of December 31, 2022 and the unaudited pro forma condensed consolidated statements of operations for the six months ended June 30, 2022 and the year ended June 30, 2022 are based on the historical consolidated financial statements of The Healing Company, Inc., a Nevada corporation (“HLCO” or the “Company”) and t
August 28, 2023	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2023 (March 3, 2023) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdic
July 31, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2023 (July 25, 2023) THE HEALING COMPANY, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporati
July 31, 2023	EX-10.1	Board of Directors Services Agreement with Steve Barr dated July 25, 2023 EXHIBIT 10.1 THE HEALING COMPANY, INC. BOARD OF DIRECTORS SERVICES AGREEMENT This Board of Directors Services Agreement (the “Agreement”), dated July 25, 2023 (the “Effective Date”), is entered into between The Healing Company, Inc., a Nevada corporation (the “Company), and Steve Barr, an individual with a principal place of residence in California (“Director”). RECITAL The Board of Directors of t
July 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2023 (July 27, 2023) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2023 (July 27, 2023) THE HEALING COMPANY, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporati
July 27, 2023	EX-99.1	Your Super’s Moon Balance Superfood Blend Reduced Period Symptoms in 86% of Clinical Trial Participants - Study Shows Daily Use of Moon Balance Resulted in Reduced Pain & Discomfort and Improved Sleep Quality & Productivity - EXHIBIT 99.1 Your Super’s Moon Balance Superfood Blend Reduced Period Symptoms in 86% of Clinical Trial Participants - Study Shows Daily Use of Moon Balance Resulted in Reduced Pain & Discomfort and Improved Sleep Quality & Productivity - New York, NY, July 27, 2023 (Globe Newswire) - The Healing Company (OTCQB: HLCO) (“The Healing Company” or the “Company”) and its portfolio company Your Super, t
July 7, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2023 (May 26, 2023) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2023 (May 26, 2023) THE HEALING COMPANY, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation
July 7, 2023	EX-10.4	Put Option Agreement dated June 30, 2023 by and between The Healing Company Inc. and DRF Althea (UK) Limited EXHIBIT 10.4 Execution Copy THE HEALING COMPANY INC. PUT OPTION AGREEMENT This Put Option Agreement (the “Agreement”) is made as of June 30, 2023, by and between The Healing Company Inc., a Nevada corporation (the “Company,” “we,” “us” or “our”), and DRF ALTHEA (UK) LIMITED, a company registered with the Registrar of companies in the United Kingdom with company number 12744781 (the “Subscriber” or
July 7, 2023	EX-10.1	Subscription Agreement dated June 30, 2023 by and between Chopra HLCO LLC and Althea DRF Lifesciences Limited EXHIBIT 10.1 Execution Copy CHOPRA HLCO LLC SECURITIES SUBSCRIPTION AGREEMENT THIS SECURITIES SUBSCRIPTION AGREEMENT (the “Agreement”) is made as of June 30, 2023, by and between CHOPRA HLCO LLC, a Delaware limited liability company (the “Company,” “we,” “us” or “our”), and ALTHEA DRF LIFESCIENCES LIMITED, a company registered with the Registrar of companies in India with company number U33110DL20
July 7, 2023	EX-10.2	Subscription Agreement dated June 30, 2023 by and between Chopra HLCO LLC and DRF Althea (UK) Limited EXHIBIT 10.2 Execution Copy CHOPRA HLCO LLC SECURITIES SUBSCRIPTION AGREEMENT This Securities Subscription Agreement (the “Agreement”) is made as of June 30, 2023, by and between Chopra HLCO LLC, a Delaware limited liability company (the “Company,” “we,” “us” or “our”), and DRF ALTHEA (UK) LIMITED, a company registered with the Registrar of companies in the United Kingdom with company number 12744
July 7, 2023	EX-10.5	Intellectual Property Assignment Transfer Agreement dated June 30, 2023 by and between The Healing Company Inc. and DRF Althea (UK) Limited EXHIBIT 10.5 INTELLECTUAL PROPERTY ASSIGNMENT TRANSFER AGREEMENT This Intellectual Property Assignment Transfer Agreement (this “IP Agreement”) is made as of June , 2023, by and among DRF ALTHEA (UK) LIMITED, a United Kingdom company with company number 12744781 (“Althea”) and The Healing Company Inc., an Nevada corporation (“Healing Company”) (Althea and Healing Company, collectively, the “Partie
July 7, 2023	EX-10.6	Board of Directors Services Agreement with Ameeth Sakaran dated May 26, 2023 EXHIBIT 10.6 THE HEALING COMPANY, INC. BOARD OF DIRECTORS SERVICES AGREEMENT This Board of Directors Services Agreement (the “Agreement”), dated May 26, 2023 (the “Effective Date”), is entered into between The Healing Company, Inc., a Nevada corporation (the “Company), and Ameeth Sankaran, an individual with a principal place of residence in Dallas, TX (“Director”). RECITAL The Board of Directors
July 7, 2023	EX-10.3	Put Option Agreement dated June 30, 2023 by and between The Healing Company Inc. and Althea DRF Lifesciences Limited EXHBIIT 10.3 Execution Copy THE HEALING COMPANY INC. PUT OPTION AGREEMENT THIS PUT OPTION AGREEMENT (the “Agreement”) is made as of June 30, 2023, by and between THE HEALING COMPANY INC., a Nevada corporation (the “Company,” “we,” “us” or “our”), and ALTHEA DRF LIFESCIENCES LIMITED, a company registered with the Registrar of companies in India with company number U33110DL2008PLC185857 (the “Subscr
July 7, 2023	EX-99.1	The Healing Company Uplists to the OTCQB Venture Market and Secures New Strategic Investors EXHIBIT 99.1 The Healing Company Uplists to the OTCQB Venture Market and Secures New Strategic Investors · Uplists from the OTC Pink Market to the OTCQB Venture Market; continues trading under ticker HLCO · Secures up to $7M in new funding from strategic partners including billion-dollar investment office of the Burman family (New Delhi) and the Goetz Family Office (Munich) · Including previously
May 19, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (Commission File Number) 000-56551 THE HEALING COMPANY IN
May 15, 2023	NT 10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-56551 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-56551 ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: March 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report
May 10, 2023	8-A12G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 26-2862618 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
May 2, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2023 (May 2, 2023) THE HEALING COMPANY, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation)
April 26, 2023	EX-3.1	Certificate of Amendment filed with the Nevada Secretary of State on April 26, 2023 (incorporated by reference to our Current Report on Form 8-K filed on April 25, 2023) EXHIBIT 3.1
April 26, 2023	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2023 (April 20, 2023) THE HEALING COMPANY, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorpora
March 9, 2023	EX-99.1	Your Super, Inc. and Subsidiaries Unaudited Condensed Consolidated Financial Statements As of and for the nine months ended September 30, 2022 and Notes to Unaudited Consolidated Financial Statements EXHIBIT 99.1 Your Super, Inc. and Subsidiaries Unaudited Condensed Consolidated Financial Statements As of and for the nine months ended September 30, 2022 and Notes to Unaudited Consolidated Financial Statements 1 Your Super, Inc. and Subsidiaries Index to Unaudited Condensed Consolidated Financial Statements Pages Unaudited Condensed Consolidated Financial Statements 2 Unaudited Condensed Consol
March 9, 2023	EX-99.2	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION EXHIBIT 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following unaudited pro forma condensed combined financial information includes the historical results of the operating subsidiaries acquired from Your Super, Inc., a Delaware corporation, including Your Superfoods, B.V. (“YSF BV”), a Netherlands corporation and subsidiaries Your Superfoods GmbH (“YSF GmbH”), a German co
March 9, 2023	8-K/A	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 2 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2023 (October 13, 2022) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdi
March 7, 2023	EX-10.4	Bill of Sale, dated as of March 3, 2023, of Chopra Global, LLC. EXHIBIT 10.4 BILL OF SALE For good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Chopra Global, LLC, a Delaware limited liability company (“Seller”), hereby sells, assigns, transfers, conveys and delivers to The Healing Company Inc., a Nevada corporation (“HLCO”), and Chopra HLCO, LLC, a Delaware limited liability company and indirect wholly owned subsidiar
March 7, 2023	EX-10.1	Lock Up/Leak Out Agreement, dated as of March 3, 2023, by and between the Company and Chopra Global, LLC. EXHIBIT 10.1 LOCK UP/LEAK OUT AGREEMENT THIS LOCK UP/LEAK OUT AGREEMENT (the “Agreement “) is entered into as of this 3rd day of March 2023 by and between The Healing Company Inc., a Nevada corporation (the “Company “), and Chopra Global, LLC, a Delaware limited liability company (the “Stockholder “). WHEREAS, the Company and the Stockholder are parties to that certain Asset Purchase Agreement (th
March 7, 2023	EX-10.2	License Agreement, effective as of March 3, 2023, by and among the Company, Chopra HLCO and Chopra Global, LLC. EXHIBIT 10.2 LICENSE AGREEMENT This License Agreement (the “Agreement”), effective as of March 3, 2023 (the “Effective Date”), is made by and among Chopra Global, LLC, a Delaware limited liability company (“Licensor”), THE HEALING COMPANY INC., a Nevada corporation (“HLCO”), and Chopra HLCO, LLC, a Delaware limited liability company and indirect wholly owned subsidiary of HLCO in which the acquire
March 7, 2023	EX-2.1	Asset Purchase Agreement, dated as of March 3, 2023, by and among the Company, Chopra HLCO and Chopra Global, LLC, and solely with respect to indemnification provisions, Deepak Chopra. EXHIBIIT 2.1 ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of March 3, 2023 (“Effective Date”), is entered into by and among THE HEALING COMPANY INC., a Nevada corporation (“HLCO”), Chopra HLCO, LLC, a Delaware limited liability company and indirect wholly owned subsidiary of HLCO in which the to be acquired Business (as defined below) will be held and operate
March 7, 2023	EX-10.3	Assignment and Assumption Agreement, effective as of March 3, 2023, by and among the Company, Chopra HLCO and Chopra Global, LLC. EX-10.3 5 thccex103.htm ASSIGNMENT AND ASSUMPTION AGREEMENT EXHIBIT 10.3 Assignment and Assumption Agreement THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Agreement”), effective as of March 3, 2023 (the “Effective Date”), is made by and among Chopra Global, LLC, a Delaware limited liability company (“Seller”), and The Healing Company Inc., a Nevada corporation (“HLCO”), and Chopra HLCO LLC, a De
March 7, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2023 (March 3, 2023) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2023 (March 3, 2023) THE HEALING COMPANY, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporati
March 7, 2023	EX-99.1	ENDS EXHIBIT 99.1 HL: The Healing Company [OTC: HLCO] acquires Chopra Global’s wellbeing experiences businesses, deepening partnership with wellness icon, Dr. Deepak Chopra · This is the second acquisition in four months for The Healing Company, who acquired leading plant-based superfoods brand Your Super, late last year · The Chopra Global wellbeing experiences businesses, including physical products,
March 3, 2023	8-K/A	Entry into a Material Definitive Agreement, 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 (October 13, 2022) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jur
March 3, 2023	EX-99.1	Your Super, Inc. and Subsidiaries Consolidated Financial Statements As of and for the years ended December 31, 2021 and 2020 and Notes to Consolidated Financial Statements and Independent Auditors’ Reports EXHIBIT 99.1 Your Super, Inc. and Subsidiaries Consolidated Financial Statements As of and for the years ended December 31, 2021 and 2020 and Notes to Consolidated Financial Statements and Independent Auditors’ Reports 1 Your Super, Inc. and Subsidiaries Index to Consolidated Financial Statements Pages Independent Auditors’ Reports 3 Consolidated Financial Statements Consolidated Balance Sheets as
March 1, 2023	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (Commission File Number) 333-152805
February 28, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (Commission File Number) 333-152805 THE HEALING COMPAN
February 27, 2023	EX-10.2	Amendment to Restricted Stock Award Agreement, dated February 21, 2023, between the Company and Amit Kapur. (incorporated by reference to our Current Report on Form 8-K filed on February 27, 2023) EX-10.2 3 thccex102.htm AMENDMENT TO RESTRICTED STOCK AWARD AGREEMENT EXHIBIT 10.2 AMENDMENT TO RESTRICTED STOCK AWARD AGREEMENT This Amendment (the “Amendment”) is made and entered into as of the Effective Date (as that term is defined in the Separation Agreement (as that term is defined herein below)) by and between Amit Kapur, an individual (the “Executive” or “Kapur”), and The Healing Company
February 27, 2023	EX-10.1	Separation Agreement and Release of Claims, dated February 21, 2023, between the Company and Amit Kapur. (incorporated by reference to our Current Report on Form 8-K filed on February 27, 2023) EXHIBIT 10.1 SEPARATION AGREEMENT AND RELEASE OF CLAIMS This SEPARATION AGREEMENT AND RELEASE OF CLAIMS (the “Separation Agreement”) is made by and between Amit Kapur, an individual (the “Executive” or “Kapur”), and The Healing Company Inc., a Nevada corporation (the “Company”). The Company and the Executive are collectively referred to as the “Parties” an each is individually referred to as a “Pa
February 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2023 THE HEALING COMPANY, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation) (Commiss
February 14, 2023	NT 10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-152805 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-152805 ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Re
November 15, 2022	NT 10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-152805 NT 10-Q 1 thccnt10q.htm NT 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-152805 ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: September 30, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Re
November 15, 2022	EX-10.6	Supplement to Guarantee and Collateral Agreement dated as of August 4, 2022 between Your Super HLCO LLC and Westmount Group, LLC (incorporated by reference to our Quarterly Report on Form 10-Q filed on November 15, 2022) EX-10.6 3 hlcoex106.htm SUPPLEMENT TO GUARANTEE AND COLLATERAL AGREEMENT EXHIBIT 10.6 SUPPLEMENT TO GUARANTEE AND COLLATERAL AGREEMENT This SUPPLEMENT (this “Supplement”) dated as of October 20, 2022 to the Guarantee and Collateral Agreement dated as of August 4, 2022 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Guarantee and Collateral Ag
November 15, 2022	EX-10.7	Limited Waiver to Credit Agreement originally dated August 4, 2022, as of October 27, 2022 (incorporated by reference to our Quarterly Report on Form 10-Q filed on November 15, 2022) EX-10.7 4 hlcoex107.htm LIMITED WAIVER TO CREDIT AGREEMENT EXHIBIT 10.7 LIMITED WAIVERTO CREDIT AGREEMENT THIS LIMITED WAIVER TO CREDIT AGREEMENT (this “Limited Waiver”), dated as of October 27, 2022 (the “Effective Date”), is entered into by and among HLCO BORROWER, LLC, a Delaware limited liability company (“Company”), THE HEALING COMPANY INC., a Nevada corporation (“Parent”), the Lenders party
November 15, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (Commission File Number) 333-152805 THE HEALING COMPA
November 15, 2022	EX-4.1	Amended and Restated Warrant dated August 4,2022 issued to Westmount Group LLC (incorporated by reference to our Quarterly Report on Form 10-Q filed on November 15, 2022) EX-4.1 2 hlcoex41.htm AMENDED AND RESTATED WARRANT EXHIBIT 4.1 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ”ACT”), OR QUALIFIED UNDER ANY STATE, FEDERAL, OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGIST
October 27, 2022	8-K	Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2022 (October 7, 2022) THE HEALING COMPANY, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorp
October 27, 2022	EX-10.1	Form of Subscription Agreement EXHIBIT 10.1 THE HEALING COMPANY Inc. SEED PREFERRED STOCK SUBSCRIPTION AGREEMENT This Seed Preferred Stock Subscription Agreement (the ?Agreement?) is made as of , 2022, by and among The Healing Company Inc., a Nevada corporation (the ?Company,? ?we,? ?us? or ?our?), and the person or entity named on the signature page hereto (the ?Subscriber?). Recitals We are offering and selling to the Subscri
October 18, 2022	EX-2.1	Asset Purchase Agreement, dated as of October 13, 2022, by and among The Healing Company Inc., HLCO Borrower, LLC, Your Super, Inc., and Shareholder Representative Services LLC (incorporated by reference to our Current Report on Form 8-K filed on October 18, 2022) EXHIBIT 2.1 ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (this ?Agreement?), dated as of October 13, 2022, is entered into by and among The Healing Company Inc., a Nevada corporation (?HLCO?), HLCO Borrower, LLC, a Delaware limited liability company (either being referred to as ?Buyer?), Your Super, Inc., a Delaware corporation (?Seller?), and Shareholder Representative Services LLC, a C
October 18, 2022	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2022 (October 13, 2022) THE HEALING COMPANY, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incor
October 18, 2022	EX-99.2	Email dated October 17, 2022 EXHIBIT 99.2
October 18, 2022	EX-10.2	Form of Consulting Agreement by and between Your Super HLCO LLC and Kristel De Groot (incorporated by reference to our Current Report on Form 8-K filed on October 18, 2022) EX-10.2 4 thccex102.htm CONSULTING AGREEMENT EXHIBIT 10.2 CONSULTING AGREEMENT This CONSULTING AGREEMENT (the “Agreement”) is made and entered into as of the 14th day of October, 2022 (the “Effective Date”), by and between Your Super HLCO LLC, a Delaware limited liability company (the “Company”) and wholly owned subsidiary of The Healing Company Inc. (“HLCO”), and Kristel De Groot, an individual (
October 18, 2022	EX-10.1	Form of Employment Agreement by and between Your Super HLCO LLC and Michael Kuech (incorporated by reference to our Current Report on Form 8-K filed on October 18, 2022) EX-10.1 3 thccex101.htm EMPLOYMENT AGREEMENT EXHIBIT 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of the 14th day of October, 2022 (the “Effective Date”), by and between Your Super HLCO LLC, a Delaware limited liability company (the “Company”) and wholly owned subsidiary of The Healing Company Inc. (“HLCO”), and Michael Kuech, an individual (“Em
October 18, 2022	EX-99.1	The Healing Company acquires leading superfoods business, Your Super, and lands $150M credit facility to expand community of brands EXHIBIT 99.1 The Healing Company acquires leading superfoods business, Your Super, and lands $150M credit facility to expand community of brands PR Newswire NEW YORK, Oct. 17, 2022 ? Your Super ranked #1 in the food and beverage category on Inc.?s 2021 5000 fastest growing company list, placing 25th overall with three-year revenue growth of 11,477 percent and $180M in cumulative revenue ? The Heal
October 12, 2022	EX-10.26	Consulting agreement between the Company and Lee Forster dated September 1, 2022 EXHIBIT 10.26 THE HEALING COMPANY, INC. CONSULTING AGREEMENT This Consulting Agreement (this “Agreement”) is made and entered into as of September 1, 2022 (the “Effective Date”) by and between The Healing Company, Inc., a Nevada corporation with its principal place of business at 711 S. Carson Street, Suite 4, Carson City, Nevada 89701 (the “Company”), and Lee Forster, an address of 31 Barmouth Ro
October 12, 2022	EX-10.28	Form of Stock Option agreement under the 2022 Omnibus Plan EXHIBIT 10.28 STOCK OPTION AGREEMENT This Stock Option Agreement (this ?Agreement?) is made and entered into as of the Grant Date specified below by and between The Healing Company Inc., a Nevada corporation (the ?Company?), and the participant named below (the ?Participant?). Name of Participant: Grant Date: Expiration Date: Exercise Price: $0.001 Number of Option Shares: Type of Option: Vesting
October 12, 2022	EX-10.16	Guarantee and Collateral Agreement dated August 4, 2022 by and among the Registrant, HLCO Borrower, LLC and certain other persons party thereto (incorporated by reference to our Annual Report on Form 10-K filed on October 12, 2022) EXHIBIT 10.16 GUARANTEE AND COLLATERAL AGREEMENT dated as of August 4, 2022 among HLCO BORROWER, LLC, as Grantor the other Grantors from time to time party hereto, and WESTMOUNT GROUP LLC, as Collateral Agent Table of Contents Page ARTICLE I DEFINITIONS 1 SECTION 1.01. Credit Agreement 1 SECTION 1.02. Other Defined Terms 1 SECTION 1.03. Independence of Covenants 5 ARTICLE II GUARANTEE 5 SECTION 2.
October 12, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-152805 THE HEALING COMPANY INC. (Exact
October 12, 2022	EX-10.25	Amendment to Services Agreement between the Company and Flight Story Limited dated September 1, 2022 EX-10.25 12 hlcoex1025.htm AMENDMENT TO SERVICES AGREEMENT EXHIBIT 10.25 FIRST AMENDMENT TO AGREEMENT OF SERVICES This First Amendment, dated September 1, 2022 (the “First Amendment”), shall form a part of that certain Agreement of Services, dated January 10, 2022 (the “Services Agreement”), by and between FLIGHT STORY LIMITED, a company registered in England (“FSL”) and THE HEALING COMPANY INC.,
October 12, 2022	EX-10.27	Form of Agreement, Restricted Stock Award EXHIBIT 10.27 RESTRICTED STOCK AWARD AGREEMENT This Restricted Stock Award Agreement (this ?Agreement?) is made and entered into as of [ ] (the ?Grant Date?) by and between The Healing Company Inc., a Nevada corporation (the ?Company?), and [ ] (the ?Grantee?). WHEREAS, the Company has adopted The Healing Company Inc. 2022 Omnibus Equity Incentive Plan (the ?Plan?) pursuant to which awards of Rest
October 12, 2022	EX-10.17	Pledge Agreement between the Company and the Lender EXHIBIT 10.17 PLEDGE AGREEMENT THIS PLEDGE AGREEMENT (as may be amended, restated, amended and restated, supplemented or otherwise modified from time to time, this ?Agreement?) dated as of August 4, 2022, is executed by THE HEALING COMPANY INC., a Nevada corporation (?Pledgor?), in favor of WESTMOUNT GROUP LLC, a Delaware limited liability company, as administrative and collateral agent for itself
October 12, 2022	EX-10.29	Form of Stock Option agreement, outside 2022 Omnibus Plan EXHIBIT 10.29 THE HEALING COMPANY INC. OPTION AGREEMENT THIS OPTION AGREEMENT (this “Agreement”) dated [ ] , 2022, by and between The Healing Company Inc., a Nevada corporation (the “Company”), and [ ] (the “Option Holder”). RECITAL Pursuant to an agreement between the Company and the Option Holder, the Company agreed to grant an option to the Option Holder for the purchase of [ ] shares of the Co
October 12, 2022	EX-10.21	Collateral Assignment of Servicing Agreement between the Company and the Lender EXHIBIT 10.21 COLLATERAL ASSIGNMENT OF SERVICING AGREEMENT THIS COLLATERAL ASSIGNMENT OF SERVICING AGREEMENT (this“Assignment”), dated and effective as of August 4, 2022, is made by HLCO BORROWER, LLC, a Delaware limited liability company (“Assignor”), in favor of WESTMOUNT GROUP LLC, a Delaware limited liability company, as administrative and collateral agent for the Lenders (“Administrative Agen
October 12, 2022	EX-10.19	Master Escrow Agreement between the Company and the Lender EXHIBIT 10.19 MASTER ESCROW AGREEMENT THIS ESCROW AGREEMENT (“Agreement”), dated August 4, 2022, is by and among (1) Westmount Group LLC, a Delaware limited liability company (“Agent”); (2) The Healing Company Inc., a Nevada corporation (“Parent”) and its wholly owned subsidiary, HLCO Borrower, LLC, a Delaware limited liability company (“Borrower” and together with Parent, collectively, “Company”)
October 12, 2022	EX-10.24	Amendment to Simon Belsham Employment Agreement dated September 1, 2022 EXHIBIT 10.24 AMENDMENT TO EMPLOYMENT AGREEMENT This AMENDMENT TO EMPLOYMENT AGREEMENT (the “Amendment”), dated as of September 1, 2022, is made by and between The Healing Company Inc. a Nevada corporation (the “Company”) and Simon Belsham (the “Executive”). RECITALS WHEREAS, reference is made to that certain Employment Agreement, dated as of November 27, 2021, by and between the Company and the E
October 12, 2022	EX-10.15	Credit Agreement dated August 4, 2022 by and among the Registrant, HLCO Borrower, LLC and certain other persons party thereto (incorporated by reference to our Annual Report on Form 10-K filed on October 12, 2022) EXHIBIT 10.15 Execution Version CREDIT AGREEMENT dated as of August 4, 2022 among HLCO BORROWER, LLC, as Borrower, THE HEALING COMPANY INC., as Parent, THE LENDERS PARTY HERETO, and WESTMOUNT GROUP LLC, as Administrative Agent and Collateral Agent Up to $150,000,000 Credit Facility TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INTERPRETATION 6 Section 1.1 Definitions. 6 Section 1.2 Accounting T
October 12, 2022	EX-10.14	Consulting Agreement between the Company and RayRos Holdings LLC dated August 1, 2022 EXHIBIT 10.14 THE HEALING COMPANY, INC. CONSULTING AGREEMENT This Consulting Agreement (this “Agreement”) is made and entered into as of August 1, 2022 (the “Effective Date”) by and between The Healing Company, Inc., a Nevada corporation with its principal place of business at 711 S. Carson Street, Suite 4, Carson City, Nevada 89701 (the “Company”), and RayRos Holdings, LLC, a Connecticut Limited
October 12, 2022	EX-21	List of subsidiaries, EX-21 17 hlcoex21.htm LIST OF SUBSIDIARIES EXHIBIT 21 List of Subsidiaries Subsidiaries of The Healing Company Inc.: NOEO, GmbH, a German Corporation, 100% controlled NOEO, Inc., a Nevada Corporation, 100% controlled HLCO Borrower LLC, a Delaware Corporation, 100% controlled Subsidiary of HLCO Borrower LLC: Your Super HLCO LLC, a Delaware Corporation, 100% controlled
October 12, 2022	EX-10.20	Collateral Assignment of Purchase Agreement between the Company and the Lender EXHIBIT 10.20 COLLATERAL ASSIGNMENT OF PURCHASE AGREEMENT THIS COLLATERAL ASSIGNMENT OF PURCHASE AGREEMENT (this“Assignment”), dated and effective as of August 4, 2022, is made by THE HEALING COMPANY INC., a Nevada corporation (“Parent”), HLCO BORROWER, LLC, a Delaware limited liability company (“Company”), and each Subsidiary of Company party hereto or which may become party hereto as required by
October 12, 2022	EX-10.18	Guaranty between the Company and the Lender EXHIBIT 10.18 GUARANTY FOR VALUE RECEIVED, and in consideration of any loan or other financial accommodation heretofore or hereafter at any time made or granted to HLCO BORROWER, LLC, a Delaware limited liability company (“Company”) pursuant to the Credit Agreement (defined below), THE HEALING COMPANY INC., a Nevada corporation (“Guarantor”) hereby agrees, in favor of the Lenders and the Administr
October 12, 2022	EX-10.22	Warrant Agreement EXHIBIT 10.22 Execution Version THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR QUALIFIED UNDER ANY STATE, FEDERAL, OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH
September 28, 2022	NT 10-K	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-1492617 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-1492617 ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For period ended: June 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Repor
September 21, 2022	EX-10.1	Loan Purchase and Sale Agreement dated September 9, 2022, by and between The Healing Company Inc. and CircleUp Credit Advisors LLC (incorporated by reference to our Current Report on Form 8-K filed on September 21, 2022) EX-10.1 2 thccex101.htm LOAN PURCHASE AND SALE AGREEMENT EXHIBIT 10.1 LOAN PURCHASE AND SALE AGREEMENT THIS LOAN PURCHASE AND SALE AGREEMENT (this “Agreement”) is made and entered into effective as of September 09, 2022 (the “Effective Date”) by and between CircleUp Credit Advisors LLC, a Delaware limited liability company (“Seller”), and The Healing Company Inc., a Nevada corporation (“Buyer”). C
September 21, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 21, 2022 (September 9, 2022) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of inco
September 7, 2022	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2022 (September 2, 2022) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of inco
September 7, 2022	EX-16.1	Letter from Prager Metis CPAs, LLP dated September 7, 2022 regarding change in certified accountant. EX-16.1 2 thccex161.htm LETTER EXHIBIT 16.1 September 7, 2022 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Dear Sir/Madam: We have read the statements included under Item 4.01 in the Form 8-K dated September 2, 2022, of The Healing Company, Inc. (the "Company") to be filed with the Securities and Exchange Commission regarding the change
September 2, 2022	8-K/A	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 2, 2022 (March 10, 2022) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorp
September 2, 2022	EX-99.1	NOEO GmbH, Berlin Audited Financial Statements For the period March 9, 2021, to December 31, 2021 EXHIBIT 99.1 NOEO GmbH, Berlin Audited Financial Statements For the period March 9, 2021, to December 31, 2021 1 NOEO GmbH, Berlin INDEX TO FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-1 Balance Sheets as of December 31, 2021, F-2 Statements of Operations for the Period ended December 31, 2021, F-3 Statements of Stockholders? Equity for the Period ended Decem
August 24, 2022	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 24, 2022 (August 4, 2022) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporat
July 25, 2022	EX-3.1	Certificate of Amendment filed with the Nevada Secretary of State on July 19, 2022 (incorporated by reference to our Current Report on Form 8-K filed on July 25, 2022) EX-3.1 2 thcc31.htm CERTIFICATE OF AMENDMENT EXHIBIT 3.1
July 25, 2022	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 19, 2022 THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation) (Commission Fi
July 12, 2022	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-152805 (Commission File Number) THE
July 12, 2022	EX-10.1	2022 Omnibus Incentive Plan (incorporated by reference to our Current Report on Form 8-K filed on July 12, 2022) EXHIBIT 10.1 THE HEALING COMPANY INC. 2022 OMNIBUS EQUITY INCENTIVE PLAN EFFECTIVE DATE: June 10, 2022 APPROVED BY SHAREHOLDERS: June 10, 2022 EXPIRATION DATE: June 9, 2033 ARTICLE 1 ESTABLISHMENT; PURPOSE; GLOSSARY 1.1 ESTABLISHMENT. The Healing Company Inc., a Nevada corporation (the “Company”), hereby establishes the Healing Company Inc. 2022 Omnibus Equity Incentive Plan (the “Plan”). 1.2 PURP
July 12, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 12, 2022 (June 10, 2022) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation
June 30, 2022	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 29, 2022 (June 22, 2022) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation
June 14, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 14, 2022 (June 6, 2022) THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation)
June 14, 2022	EX-10.1	Offer Letter to Amit Kapur dated June 2, 2022 EXHIBIT 10.1 Amit Kapur 1300 N. Cleveland Ave Chicago, IL 60610 June 2, 2022 Dear MR. Kapur, Offer and Position We are very pleased to extend an offer of employment to you for the position of Chief Financial Officer, Secretary and Treasurer (“CFO”) of The Healing Company, Inc., a Nevada corporation (the “Company”). This offer of employment (“Offer Letter”) is conditioned on your satisfactory compl
May 25, 2022	EX-10.14	Board Service Agreement between the Company and Kay Koplovitz, filed herewith EXHIBIT 10.14 THE HEALING COMPANY, INC. BOARD OF DIRECTORS SERVICES AGREEMENT This Board of Directors Services Agreement (the ?Agreement?), dated April 1, 2022 (the ?Effective Date?), is entered into between The Healing Company, Inc., a Nevada corporation (the ?Company), and Kay Koplovitz, an individual with a principal place of residence in New York, NY (?Director?). WHEREAS, the Company desires
May 25, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-152805 (Commission File Number) THE HEALING COMPANY I
May 16, 2022	NT 10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-1492617 NT 10-Q 1 ntform10qthcc.htm NT 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-1492617 ☐Form 10-K ☐Form 20-F ☐Form 11-K ☒Form 10-Q ☐Form 10-D ☐Form N-SAR ☐ Form N-CSR For period ended: March 31, 2022 ☐ Transition Report on Form 10-K ☐Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐Transition Report on
March 28, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 23, 2022 THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation) (Commission F
March 15, 2022	EX-10.12	Purchase and Transfer Agreement between the Company and Anabel Oelmann dated March 10, 2022(incorporated by reference to our Current Report on Form 8-K filed on March 15, 2022). EXHIBIT 10.12 (1) ANABEL JOHANNA LENA OELMANN (2) THE HEALING COMPANY INC. SHARE PURCHASE AND TRANSFER AGREEMENT THIS SHARE PURCHASE AND TRANSFER AGREEMENT (the “Agreement”) is made on March 10th 2022 BETWEEN: (1) ANABEL JOHANNA LENA OELMANN, born January 7th, 1997 and business-addressed at c/o HAUSplus GmbH, Hohenzollerndamm 125, 14199 Berlin, Germany (the “Seller”) (2) THE HEALING COMPANY INC.,
March 15, 2022	8-K	Unregistered Sales of Equity Securities, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest event Reported): March 10, 2022 The Healing Company Inc. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of (Commission (IRS Employer i
March 15, 2022	EX-10.13	Form of Seed preferred Subscription agreement (incorporated by reference to our Current Report on Form 8-K filed on March 15, 2022) EX-10.13 3 thccex1013.htm FORM OF SUBSCRIPTION AGREEMENT EXHIBIT 10.13 The Healing Company Inc. INVESTOR SUBSCRIPTION AGREEMENT (the “Subscription Agreement”) dated January , 2022 between The Healing Company Inc., a Nevada corporation (the “Company”) and the person or persons executing this Agreement on the last page (the “Subscriber”). All documents mentioned herein are incorporated by reference.
March 15, 2022	EX-21	List of subsidiaries EXHIBIT 21 List of Subsidiaries NOEO GmbH, a German company
February 22, 2022	EX-10.5	Employment Agreement between the Company and Simon Belsham dated November 27, 2021, (incorporated by reference to our Quarterly Report on Form 10 Q filed on February 22, 2022) EX-10.5 4 thccex105.htm EMPLOYMENT AGREEMENT EXHIBIT 10.5 The Healing Company Inc. Employment Agreement Dated as of November 27, 2021 Simon Belsham 1101 Grand Street, Apt 501 Hoboken, New Jersey 07030 This letter (the "Agreement") will confirm of the terms of your employment with The Healing Company Inc. (the "Company"). 1. Position and Duties; Term. (a) Effective as of the date first above writte
February 22, 2022	EX-10.3	Engagement Agreement between the Company and Administrative Services LLC dated November 1, 2021, (incorporated by reference to our Quarterly Report on Form 10 Q filed on February 22, 2022) EXHIBIT 10.3 ENGAGEMENT AGREEMENT This ENGAGEMENT AGREEMENT (the “Agreement”), made effective as of November 1, 2021 (the “Effective Date”), between The Healing Company, Inc. with an address of 711 South Carson Street, Suite #4 Carson City ,Nevada, 89701 (the “Company”) and Administrative Services LLC (“Administrative”) with an address of 15954 Jackson Creek Parkway, Monument, CO 80132 and Lee Lar
February 22, 2022	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITI UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-152805 (Commission File Number)
February 22, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-152805 (Commission File Number) THE HEALING COMPAN
February 22, 2022	EX-10.8	Services Agreement between the Company and Flight Story Limited dated January 10, 2022. (incorporated by reference to our Quarterly Report on Form 10 Q filed on February 22, 2022) EX-10.8 7 thccex108.htm SERVICES AGREEMENT EXHIBIT 10.8 AGREEMENT OF SERVICES THIS CONTRACT IS ENTERED INTO ON 10th January 2022 BETWEEN: (1) FLIGHT STORY LIMITED a company registered in England whose registered office is at 4th Floor 131 Shoreditch High Street, London, E1 6JE and registered number is 13441974 (FSL); and (2) THE HEALING COMPANY a company registered in USA whose registered office i
February 22, 2022	EX-10.4	Employment Agreement between the Company and Kelly Zuar dated November 15, 2021. (incorporated by reference to our Quarterly Report on Form 10 Q filed on February 22, 2022) EX-10.4 3 thccex104.htm EMPLOYMENT AGREEMENT EXHIBIT 10.4 Kelly Zuar 57 Gordonhurst Ave Montclair, NJ 07043 November 15th 2021 Dear Ms. Zuar, We are very pleased to offer you the position of Executive Business Partner (“EBP”), reporting to the CEO, with The Healing Company, Inc., a Nevada corporation (the “Company”). This offer of at-will employment is conditioned on your satisfactory completion o
February 22, 2022	EX-10.1	Engagement Agreement between the Company and Lee Larson Elmore dated May 1, 2021, (incorporated by reference to our Quarterly Report on Form 10 Q/A filed on February 22, 2022). EX-10.1 2 thccex101.htm ENGAGEMENT AGREEMENT EXHIBIT 10.1 ENGAGEMENT AGREEMENT This ENGAGEMENT AGREEMENT (the “Agreement”), made effective as of May 1, 2021 (the “Effective Date”), between Lake Forest Minerals, Inc. with an address of 711 South Carson Street, Suite #4 Carson City ,Nevada, 89701 (the “Company”) and Lee Larson Elmore (“Elmore”) with an address of 15954 Jackson Creek Parkway, Monumen
February 22, 2022	EX-10.10	Services Agreement between the Company and R Agency dated February 7, 2022. (incorporated by reference to our Quarterly Report on Form 10 Q filed on February 22, 2022) EX-10.10 8 thccex1010.htm SERVICES AGREEMENT EXHIBIT 10.10 R. Agency (Rebecca Abigail PR LTD) 4th Floor 12 Little Portland Street London W1W 8BJ Katie Tobias The Healing Company 711 S Carson Street Suite 4 Carson City NV 89701 USA 18.01.22 Dear Katie, I write to conﬁrm the terms on which The Healing Company (the Customer) has instructed Rebecca Abigail PR Limited (R Agency). This letter agreement
February 22, 2022	EX-10.7	Independent Contractor Agreement between the Company and KET Consulting LLC dated January 1, 2022. (incorporated by reference to our Quarterly Report on Form 10 Q filed on February 22, 2022) EXHIBIT 10.7 THE HEALING COMPANY, INC. INDEPENDENT CONTRACTOR AGREEMENT This Independent Contractor Agreement (this ?Agreement?) is made and entered into as of January 1, 2022 (the ?Effective Date?) by and between The Healing Company, Inc., a Nevada corporation with its principal place of business at 711 S. Carson Street, Suite 4, Carson City, Nevada 89701 (the ?Company?), and KET Consulting LLC,
February 22, 2022	EX-10.2	Board of Directors Services Agreement between the Company and Poonacha Machaiah, dated July 16, 2021, (incorporated by reference to our Quarterly Report on Form 10 Q/A filed on February 22, 2022). EXHIBIT 10.2 THE HEALING COMPANY, INC. BOARD OF DIRECTORS SERVICES AGREEMENT This Board of Directors Services Agreement (the ?Agreement?), dated July 16th, 2021 (the ?Effective Date?), is entered into between The Healing Company, Inc., a Nevada corporation (the ?Company), and Poonacha Machaiah, an individual with a principal place of residence in Orlando, FL (?Director?). WHEREAS, the Company desi
February 22, 2022	EX-10.11	Board of Directors Services Agreement between the Company and Steven Bartlett (incorporated by reference to our Quarterly Report on Form 10-Q filed on February 22, 2022) EXHIBIT 10.11 THE HEALING COMPANY, INC. BOARD OF DIRECTORS SERVICES AGREEMENT This Board of Directors Services Agreement (the ?Agreement?), dated 2/16/2022, (the ?Effective Date?), is entered into between The Healing Company, Inc., a Nevada corporation (the ?Company), and Steven Bartlett, an individual with a principal place of residence in [131 Shoreditch High Street, 4th Floor, London, E1 6JE] (
February 22, 2022	EX-10.6	Board Advisor Agreement between the Company and Deepak Chopra LLC, (incorporated by reference to our Quarterly Report on Form 10 Q filed on February 22, 2022) EX-10.6 5 thccex106.htm BOARD OF DIRECTORS ADVISOR AGREEMENT EXHIBIT 10.6 BOARD ADVISOR AGREEMENT This agreement (the “Agreement”) is made effective as of December 28, 2021 (“Effective Date”), by The Healing Company Inc., a Nevada corporation (the “Company”), and Deepak Chopra, LLC (the “Advisor”). The Company wishes to retain the Advisor as an outside advisor to the Company’s Board of Directors (
February 15, 2022	NT 10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-1492617 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-1492617 ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: December 31, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition R
January 24, 2022	8-K/A	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 30, 2021 THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incor
January 24, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 10, 2022 THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation) (Commission
December 3, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 30, 2021 THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation) (Commissio
November 12, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-152805 THE HEALING
October 15, 2021	EX-10.2	Form of share restriction agreement EX-10.2 5 thccex102.htm FORM OF SHARE PURCHASE AGREEMENT EXHIBIT 10.2 FORM OF AGREEMENT STOCK RESTRICTION AGREEMENT This Stock Restriction Agreement (this “Agreement”) is made as of October 8, 2021 by and among The Healing Company Inc., a Nevada corporation (“Company”), and the purchaser identified on the signature page hereto (“Purchaser”) and together the “Parties”, and each individually, a “Par
October 15, 2021	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits 8-K 1 thcc8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 7, 2021 THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of i
October 15, 2021	EX-3.1	Certificate of Amendment filed with the Nevada Secretary of State on October 7, 2021, including Amended and Restated Articles of Incorporation. EX-3.1 2 thccex31.htm CERTIFICATE OF AMENDMENT EXHIBIT 3.1
October 15, 2021	EX-10.1	Form of share purchase agreement EX-10.1 4 thccex101.htm FORM OF SHARE PURCHASE AGREEMENT EXHIBIT 10.1 FORM OF AGREEMENT THE HEALING COMPANY INC. SHARE PURCHASE AGREEMENT Dated as of October 8, 2021 1 THIS SHARE PURCHASE AGREEMENT is made on October 8, 2021 ("Agreement") AMONG: (1) THE HEALING COMPANY INC., a Nevada corporation incorporated under the laws of the State of Nevada, United States of America, having its registered add
October 15, 2021	EX-3.2	Amended and Restated Bylaws adopted October 7, 2021 EX-3.2 3 thccex32.htm AMENDED AND RESTATED BYLAWS EXHIBIT 3.2 BYLAWS OF THE HEALING COMPANY INC., a Nevada corporation ARTICLE I OFFICES Section 1.1 Registered Office. In accordance with the applicable provisions of the Nevada Revised Statutes (“NRS”), including, without limitation, NRS 78.090, the registered office of The Healing Company Inc., a Nevada corporation (the “Corporation”), shall be ma
October 14, 2021	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 333-152805 THE HEALING COMPANY
September 29, 2021	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 333-152805 CUSIP NUMBER 88336Y105 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended June 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transit
August 6, 2021	8-K	Regulation FD Disclosure, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 5, 2021 THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation) (Commission F
June 2, 2021	EX-3.1	Certificate of Amendment (incorporated by reference to our Current Report on Form 8-K filed on June 2, 2021). EX-3.1 2 lakfex31.htm CERTIFICATE OF AMENDMENT EXHIBIT 3.1
June 2, 2021	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events 8-K 1 lakf8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 2, 2021 THE HEALING COMPANY INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of inco
May 24, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 Commission file number 333-152805 10-Q 1 lakf10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of inco
May 17, 2021	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NT 10-Q 1 lakfnt10q.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-50608 CUSIP NUMBER G31413100 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended March 31, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transiti
February 3, 2021	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 31, 2021 LAKE FOREST MINERALS INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or other jurisdiction of incorporation) (Commissio
January 29, 2021	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2020 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
October 28, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization
September 8, 2020	10-K	Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 Commission file number 333-152805 Lake Forest Minerals, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of Incorporation or Organizatio
May 5, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2020 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization) 71
February 14, 2020	10-Q	LAKF / Lake Forest Minerals, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2019 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
November 6, 2019	10-Q	LAKF / Lake Forest Minerals, Inc. 10-Q - Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2019 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA 26-2862618 (State or other jurisdiction of incorporation or o
September 6, 2019	10-K	LAKF / Lake Forest Minerals, Inc. 10-K - Annual Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ☒ ☐ Annual Report Under Section 13 or 15(d) of The Securities Exchange Act of 1934 For the years ended June 30, 2019 Transition Report Under Section 13 or 15(d) of The Securities Exchange Act of 1934 For the transition period from to Commission file number 333-152805 Lake Forest Minerals, Inc.
May 15, 2019	10-Q	LAKF / Lake Forest Minerals, Inc. 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2019 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
April 11, 2019	EX-16.1	April 11, 2019 Exhibit 16.1 April 11, 2019 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Dear Sir/Madam: We have read the statements included under Item 4.01 in the Form 8-K dated April 10, 2019 of Lake Forest Minerals, Inc. (the "Company") to be filed with the Securities and Exchange Commission regarding the change of auditors. We agree with such state
April 11, 2019	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2019 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) Nevada 333-152805 26-2862618 (State or Other Jurisdiction of Incorporation) (Commissio
January 22, 2019	10-Q	LAKF / Lake Forest Minerals, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2018 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizatio
October 22, 2018	10-Q	LAKF / Lake Forest Minerals, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2018 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizati
September 6, 2018	10-K	LAKF / Lake Forest Minerals, Inc. 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2018 Commission file number 333-152805 Lake Forest Minerals, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of Incorporation or Organizati
May 2, 2018	10-Q	LAKF / Lake Forest Minerals, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2018 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
February 2, 2018	10-Q	LAKF / Lake Forest Minerals, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2017 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizatio
October 31, 2017	10-Q	Lake Forest Minerals (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2017 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizati
September 19, 2017	10-K	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2017 Commission file number 333-152805 Lake Forest Minerals, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of Incorporation or Organizati
May 4, 2017	10-Q	Lake Forest Minerals (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2017 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
January 31, 2017	10-Q	Lake Forest Minerals (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2016 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizatio
November 10, 2016	10-Q	Lake Forest Minerals (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2016 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizati
November 3, 2016	8-K	Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 31, 2016 Lake Forest Minerals Inc.
November 3, 2016	EX-16.1	EX-16.1 Exhibit 16.1 [LETTERHEAD OF SEALE AND BEERS, CPAS] November 2, 2016 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Dear Sir/Madam: We have read the statements included under Item 4.01 in the Form 8-K dated October 31, 2016 of Lake Forest Minerals Inc. (the "Company") to be filed with the Securities and Exchange Commission regarding the cha
September 23, 2016	10-K	Lake Forest Minerals (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2016 Commission file number 333-152805 Lake Forest Minerals, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of (I.R.S. Employer Incorporat
May 9, 2016	10-Q	Lake Forest Minerals (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2016 Commission File Number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
February 5, 2016	10-Q	LAKF / Lake Forest Minerals, Inc. 10-Q - Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2015 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizatio
November 9, 2015	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2015 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizati
September 29, 2015	10-K/A	10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (AMENDMENT NO. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 Commission file number 333-152805 Lake Forest Minerals, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of (I.R.S.
September 28, 2015	10-K	10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 Commission file number 333-152805 Lake Forest Minerals, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of (I.R.S. Employer Incorporat
April 30, 2015	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2015 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
February 4, 2015	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2014 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizatio
November 14, 2014	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2014 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizati
September 26, 2014	10-K	10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2014 Commission file number 333-152805 Lake Forest Minerals, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of (I.R.S. Employer Incorporat
May 7, 2014	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
February 10, 2014	10-Q	Lake Forest Minerals (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2013 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizatio
November 13, 2013	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2013 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizati
October 21, 2013	10-K/A	10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (AMENDMENT NO. 1) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of (I.R.S.
October 15, 2013	10-K	10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of (I.R.S. Employer Incorporat
October 1, 2013	NT 10-K	- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-152805 - (Check One): [X] Form 10-K [ ] Form 10-Q [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: June 30, 2013 - [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on For
May 15, 2013	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2013 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
February 14, 2013	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2012 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizatio
November 13, 2012	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2012 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizati
September 24, 2012	10-K	10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2012 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of (I.R.S. Employer Incorporat
May 9, 2012	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2012 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
February 14, 2012	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2011 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizatio
November 10, 2011	10-Q	10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2011 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizati
September 28, 2011	10-K	ANNUAL REPORT FOR THE YEAR ENDED 6-30-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2011 Commission file number 333-152805 Lake Forest Minerals, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of (I.R.S. Employer Incorporat
May 13, 2011	10-Q	QTRLY REPORT FOR THE QTR ENDED 3-31-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2011 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
February 8, 2011	10-Q	QTRLY REPORT FOR THE QTR ENDED 12-31-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2010 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizatio
November 8, 2010	10-Q	QTRLY REPORT FOR THE QTR ENDED 9-30-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2010 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizati
September 28, 2010	10-K	ANNUAL REPORT FOR THE YEAR ENDED 6-30-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2010 Commission file number 333-152805 Lake Forest Minerals, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of (I.R.S. Employer Incorporat
May 11, 2010	10-Q	QTRLY REPORT FOR THE QTR ENDED 3-31-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2010 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
February 10, 2010	10-Q	QTRLY REPORT FOR THE QTR ENDED 12-31-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2009 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizatio
November 4, 2009	10-Q	QTRLY REPORT FOR THE QTR ENDED 9-30-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2009 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizati
October 8, 2009	8-K/A	AMENDMENT NO. 1 TO FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A Amendment No.
September 24, 2009	10-K	ANNUAL REPORT FOR THE YEAR ENDED 6-30-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURUTIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2009 Commission file number 333-152805 Lake Forest Minerals, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 26-2862618 (State or Other Jurisdiction of (I.R.S. Employer Incorporat
August 11, 2009	EX-16.1	EX-16.1 Exhibit 16.1 MOORE & ASSOCIATES, CHARTERED ACCOUNTANTS AND ADVISORS PCAOB REGISTERED August 10, 2009 U. S. Securities and Exchange Commission 450 Fifth Street NW Washington DC 20549 Re: Lake Forest Minerals, Inc. Dear Sirs: We were previously the principal auditors for Lake Forest Minerals, Inc. and we reported on the financial statements of Lake Forest Minerals, Inc. for the period from inception
August 11, 2009	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 August 10, 2009 Date of report (Date of earliest event reported) LAKE FOREST MINERALS, INC.
April 30, 2009	10-Q	QTRLY REPORT FOR THE QTR ENDED 3-31-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2009 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization)
February 4, 2009	10-Q	QTRLY REPORT FOR THE QTR ENDED 12-31-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2008 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizatio
October 30, 2008	10-Q	QTRLY REPORT FOR THE QTR ENDED 9-30-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2008 Commission file number 333-152805 LAKE FOREST MINERALS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organizati
August 6, 2008	EX-3.1	Articles of Incorporation EX-3.1 2 ex3-1.txt ARTICLES OF INCORPORATION Exhibit 3.1 ROSS MILLER Secretary of State 206 North Carson Street Carson City, Nevada 89701-4298 (775) 684-5708 Website: secretaryofstate.biz Document Number 20080419373-57 Filing Date and Time: 06/23/2008 12:20 PM Entity # E0401152008-4 Filed in the office of /s/ Ross Miller Ross Miller Secretary of State State of Nevada ARTICLES OF INCORPORATION (PUR
August 6, 2008	EX-99.2	EX-99.2 Exhibit 99.2 LAKE FOREST MINERALS INC. A REPORT ON THE GEOLOGY, SOIL GEOCHEMISTRY AND MINERAL POTENTIAL OF THE VIN MINERAL CLAIM, PRINCETON MINING DIVISION BRITISH COLUMBIA (NTS 092H16) By T.L. Sadlier-Brown, P.Geo. June 30th 2008 page - TABLE OF CONTENTS SUMMARY 1 1.0 INTRODUCTION 2 1.1 Terms of Reference and Scope of Report. 2 1.2 Property Description and Claim Status 3 1.3 Location, Physiograph
August 6, 2008	S-1	FORM S-1 OF LAKE FOREST MINERALS, INC. As filed with the Securities and Exchange Commission on August 6, 2008 Registration No.
August 6, 2008	EX-3.2	By-laws (incorporated by reference to our Registration Statement on Form S-1 filed on August 6, 2008). Exhibit 3.2 BYLAWS OF LAKE FOREST MINERALS INC. ARTICLE I OFFICES Section 1.01 Location of Offices. The corporation may maintain such offices within or without the State of Nevada as the Board of Directors may from time to time designate or require. Section 1.02 Principal Office. The address of the principal office of the corporation shall be at the address of the registered office of the corporat
August 6, 2008	EX-99.1	EX-99.1 Exhibit 99.1 SUBSCRIPTION AGREEMENT FOR LAKE FOREST MINERALS INC. COMMON STOCK ($.01 PER SHARE) Persons interested in purchasing common stock of Lake Forest Minerals Inc. must complete and return this Subscription Agreement along with their check or money order to: LAKE FOREST MINERALS INC. ("the Issuer" & "the Company"). Subject only to acceptance hereof by the Issuer, in its discretion, the unde
August 6, 2008	EX-10	EX-10 Exhibit 10 MINERAL PROPERTY OPTION AGREEMENT THIS AGREEMENT dated for reference June 26, 2008.

HLCO / The Healing Company Inc. - Zgłoszenia SEC, Raport roczny, o pełnomocnictwie

Podstawowe statystyki

SEC Filings

SEC Filings (Chronological Order)

How Much do you Like Fintel?

Write a Review and get 25% Off Your Next Purchase

How can we Improve?